SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59(RR-1):127.
  • 2
    World Health Organization. Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006; 81:331340.
  • 3
    Campbell GL, Hills SL, Fischer M, et al. Estimated global frequency and incidence of Japanese encephalitis. Bull World Health Organ 2011; 89:766e774e.
  • 4
    Hills SL, Griggs AC, Fischer M. Japanese encephalitis among travelers from non-endemic countries, 1973–2008. Am J Trop Med Hyg 2010; 82:930936.
  • 5
    Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993; 42(RR-1):115.
  • 6
    Centers for Disease Control and Prevention. Update on Japanese encephalitis vaccine for children—United States, May 2011. MMWR Morb Mortal Wkly Rep 2011; 60:664665.
  • 7
    Centers for Disease Control and Prevention. Recommendations for use of a booster dose of inactivated Vero cell culture-derived Japanese encephalitis vaccine—Advisory Committee on Immunization Practices, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:661663.
  • 8
    World Tourism Organization. Yearbook of tourism statistics: data 2000–2004. Madrid, Spain: World Tourism Organization, 2006.
  • 9
    Lumley T. Survey: analysis of complex survey samples. R package version 3.24-1, 2011.
  • 10
    R development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-9000051-07-0. Available at: http://www.R-project.org. (Accessed 2011 Nov 21).
  • 11
    Cochran WG. Stratified random sampling. In: Sampling techniques. 3rd Ed. New York: John Wiley & Sons, Inc., 1977:89114.
  • 12
    Food and Drug Administration. Product approval information [package insert]. Ixiaro (Japanese encephalitis virus vaccine inactivated). Intercell Biomedical, Livingston, UK. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179132.htm. (Accessed 2011 Dec 22).
  • 13
    Fischer M, Casey C, Chen RT. Promise of new Japanese encephalitis vaccines. Lancet 2007; 370:18061808.
  • 14
    Teitelbaum P. Expert opinion on vaccination of travelers against Japanese encephalitis [correspondence]. J Travel Med 2009; 16:441.
  • 15
    Centers for Disease Control and Prevention. Japanese encephalitis in two children—United States, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:276278.
  • 16
    Jeurissen A, Strauven T. A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines. Acta Neurol Belg 2011; 11:143145.
  • 17
    Werlinrud AM, Christiansen CB, Koch A. Japanese encephalitis in a Danish short-term traveler to Cambodia. J Travel Med 2011; 18:411413.
  • 18
    Tappe D, Nemecek A, Zipp F, et al. Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. J Clin Virol 2012; 54:282285.
  • 19
    Langevin S, Libman M, Drebot MA. A case of Japanese encephalitis virus infection acquired during a trip in Thailand. J Travel Med 2012; 19:127129.
  • 20
    Lee DW, Choe YJ, Kim JH, et al. Epidemiology of Japanese encephalitis in South Korea, 2007–2010. Int J Infect Dis 2012; 16:e448e452.
  • 21
    Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002; 35:183188.
  • 22
    Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006; 43:11851193.
  • 23
    Keystone JS. Immigrants returning home to visit friends and relatives (VFRs). In: Brunette G, ed. Health information for international travel, 2012. Atlanta: US Department of Health and Human Services, Public Health Service, 2011:547551.